Amanta Healthcare Ltd
P&L
Quarterly Standalone
vs Q3 FY26
Amanta Healthcare FY26 PAT Up 42% YoY to ₹15 Cr
19 May 2026 · 19 May, 3:32 pm
Summary
Amanta Healthcare Limited reported consistent revenue momentum and strong profit growth for Q4 and FY26. For Q4FY26, revenue increased by 6.8% year-over-year to ₹76.99 crore, while Profit After Tax (PAT) surged by 28.0% to ₹5.53 crore. The full fiscal year 2026 saw revenue grow by 4.7% to ₹287.68 crore and PAT by a significant 41.7% to ₹14.88 crore, primarily supported by improved operating leverage and lower finance costs. Bhavesh Patel, Chairman & Managing Director, highlighted the company's focus on scaling high-margin SteriPort and SVP capacities, expanding market presence, and improving operational efficiencies for sustainable long-term growth.
Key Highlights
- 1
Amanta Healthcare Limited reported Q4FY26 revenue of ₹76.99 crore, an increase of 6.8% year-over-year.
- 2
For the full fiscal year 2026, the company's revenue reached ₹287.68 crore, up by 4.7% compared to the previous year.
- 3
Profit After Tax (PAT) for Q4FY26 rose significantly by 28.0% year-over-year to ₹5.53 crore.
- 4
Full fiscal year 2026 PAT demonstrated robust growth of 41.7% year-over-year, totaling ₹14.88 crore, attributed to improved operating leverage and lower finance costs.
- 5
Operating EBITDA for Q4FY26 stood at ₹16.61 crore, maintaining a margin of 22%.
- 6
The company is actively pursuing major capacity expansion for high-margin SteriPort and SVP products and expanding its presence across domestic and export markets.
Management Comments
Bhavesh Patel
FY26 has been a year of consistent progress and disciplined execution for Amanta Healthcare. We reported revenue of ₹288 crore, reflecting a growth of 5% YoY. More importantly, PAT grew strongly by 42% YoY to ₹15 crore, supported by improved operating leverage and lower finance costs, highlighting the strengthening quality of our earnings. For the quarter as well on a YoY basis, the revenue stood at ₹77 crore, up 7% YoY, while PAT increased 28% YoY to ₹5.5 crore, reflecting continued momentum in profitability. Going forward, our focus remains on scaling high-margin SteriPort and SVP capacities, expanding our presence across domestic and export markets, and improving operational efficiencies through strategic initiatives such as our captive solar power project. With differentiated manufacturing technologies, a growing product portfolio, and ongoing capacity expansion, we believe Amanta Healthcare is well- positioned to drive sustainable growth and create long-term value for all stakeholders
Informational and educational content only. Not investment advice.